ERBB2 and breast carcinoma: The other 3 breast cancer subtypes showed a lower frequency of these mutations: HR+/ERBB2+ in 15/54 (27.8%), HR-/ERBB2+ in 10/43 (23.3%) and HR-/ERBB2- in 16/68 (23.5%).